会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • FURANOPYRIDINE DERIVATIVES AS ACK1 AND LCK MODULATORS
    • 作为ACK1和LCK调节剂的呋喃亚胺衍生物
    • WO2006130160A3
    • 2007-02-22
    • PCT/US2005025725
    • 2005-07-19
    • AMGEN INCNUNES JOSEPH JMARTIN MATTHEW WWHITE RYANMCGOWAN DAVIDBEMIS JEAN EKAYSER FRANKFU JIASHENGLIU JINQIANJIAO XIANYUN
    • NUNES JOSEPH JMARTIN MATTHEW WWHITE RYANMCGOWAN DAVIDBEMIS JEAN EKAYSER FRANKFU JIASHENGLIU JINQIANJIAO XIANYUN
    • C07D491/04A61K31/4355C07D491/14
    • C07D491/04C07D491/14
    • The present invention relates to furanopyridine compounds having the general Formula (I) and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula I, methods of modulating Lck and ACK-1 enzymes and of treating various related diseases and conditions, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma, thymoma, just to name a few, in a mammal, comprising administering to the mammal a therapeutically effective amount a compound of Formula I, as described above, and methods of manufacturing medicaments comprising the compound of Formula (I).
    • 本发明涉及具有通式(I)的呋喃并吡啶化合物及其立体异构体,互变异构体,溶剂化物,药学上可接受的盐和衍生物及其前药。 本发明还包括药物组合物,其包含式I化合物,调节Lck和ACK-1酶的方法以及治疗各种相关疾病和病症,包括炎症,T细胞活化抑制,增殖,关节炎,器官移植,缺血或再灌注 损伤,心肌梗塞,中风,多发性硬化,炎性肠病,克罗恩病,狼疮,超敏反应,1型糖尿病,牛皮癣,皮炎,桥本氏甲状腺炎,干燥综合征,自身免疫性甲状腺功能亢进,艾迪生病,自身免疫性疾病,肾小球肾炎,过敏性疾病,哮喘 ,干草组织,湿疹,癌症,结肠癌,胸腺瘤,仅举几个例子,在哺乳动物中,包括向哺乳动物施用治疗有效量的如上所述的式I化合物和制备包含以下化合物的药物的方法: 式(I)。